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Abstract Monodisperse Au-silicate nanoparticles
(10.7 ± 1.6 nm in diameter) were prepared by reduction of
aqueous solution containing 2 mM HAuCl4 with sodium
citrate (1 wt.%) in a hydrosol, in which small clusters
of silicate formed by hydrolysis and polymerization of
3-aminopropyltrimethoxysilane (APTMS). APTMS cova-
lently linked to reduced gold particles through its -NH2
end-group. UV-vis spectra of the obtained Au-silicate
nanoparticles showed a peak at ∼ 690 nm due to the
interface effects between the Au and the silicate matrix.
The Au-silicate nanoparticles exhibited near-IR (NIR)
sensitivity. Cytotoxicity and limited hemocompatibility
in vitro for the prepared Au-silicate nanoparticles were
also investigated. It was shown that at lower concen-
tration (<1 µg/ml), the Au-silicate nanoparticles were
biocompatible without causing any cytotoxicity and
hemolysis.
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1. Introduction
The advance of nanotechnology requires design of new mate-
rials with unique functional properties. Synthesis of nanohy-
brid materials has received increasing attention. Reports on
the synthesis of Au-based nanohybrid systems can be found
in the literatures [1, 2]. Gold has many applications such
as immunoassay labeling [3], drug delivery [4, 5], nonlinear
optical switching [6], and Raman spectroscopy enhancement
[7]. For drug delivery, the reduction of particle size of drug
carrier to nano scale not only enables intravenous injection
and minimize possible irritant reactions at the injection site,
but also allows the carriers to penetrate the membranes of
the diseased cells, and deliver drugs to cancerous tumors [8].
We have recently investigated near infrared (NIR) sensitive
Au-Au2S composite nanoparticles as potential drug carriers
[4]. Anti-cancer drug cis-platin was released from Au-Au2S
nanoparticles under NIR irradiation [4].
Halas’ group deposited Au nanoparticles onto the acti-
vated surfaces of 120 nm silica particles for tumor therapy
and imaging [9, 10]. Though these Au-silica hybrid spheres
were NIR sensitive, the Au particles did not form a contin-
uous surface coating or shell on the silica. The adsorption
of Au was not uniform on the particle surface of silica, thus
limiting its use to applications such as drug carriers. Using
layer-by-layer self-assembly technique, Mulvaney et al. syn-
thesized uniform nanoparticles of Au cores encapsulated by
silica [11]. However, those uniform core-shell nanoparticles
did not show NIR activity.
In this paper, we report the synthesis of an NIR active
Au-silicate nanoparticles system by combining methods of
molecular self-assembly of organosilane through a sol-gel
procedure and reduction chemistry of synthesizing Au
colloids. As there is growing concern on the biosafety
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of nanoparticles in biomedical applications due to the
size and surface coating effects [12], the cytotoxicity and
hemocompatibility in vitro of the Au-silicate nanoparticles
were studied.
2. Materials and methods
2.1. Synthesis of Au-silicate nanoparticles
In a typical preparation, a hydrosol containing small clusters
of silicate was prepared by hydrolysis and polymerization
of 3-aminopropyltrimethoxysilane (APTMS) in water in the
presence of 0.1 M HCl, which acted as a catalyst for the sol-
gel reaction. The total amount of water was 100 equivalents
of total alkoxides in the solution. After aging for 4 days at
room temperature, chloroauric acid (HAuCl4·3H2O, 2 mM),
sodium citrate (Na3C6H5O7, 1 wt.%) and polyvinylpyrroli-
done (PVP, 0.1 mg/ml) were then added to this transparent
solution. The molar ratio of [APTMS]/[HAuCl4] was kept
as 4.0, PVP was used as a stabilizer in the present system.
The above mixture was then refluxed at 80◦C for 1 h. The
solution changed from yellow to dark purple. The obtained
precipitates were then centrifuged at 15,000 r.p.m., washed
several times using distilled water, and freeze-dried for fur-
ther characterization.
2.2. Characterization
The products were characterized by X-ray diffraction pat-
tern (XRD), recorded on a Bruker D8 Advance diffractome-
ter (CuKα radiation, λ = 1.5418 Å), operating at 40 mA
and 40 kV. The lattice parameter calculations were obtained
using a least-squares refinement method with peak fitting
software Origin Pro 7 (Voigt diffraction lines fitting). The av-
erage crystallite size of the particles was estimated using the
Scherrer equation. Fourier transform infrared (FTIR) spectra
were obtained by forming thin (∼100 µm) transparent KBr
pellets containing the materials of interest. The transmission
spectra were recorded by using a Bio-red spectrometer (FTS
135) at a resolution of 4 cm−1, and 256 scans were taken
in the range of 400–4000 cm−1. The solid-state 29Si cross-
polarization/magic-angle spinning (CP-MAS) NMR spectra
(59.6 MHz) were taken using a Varian INOVA300 instru-
ment with 3.5 kHz specimen spinning, 2.5 ms contact time,
5.0 µs pulse width, 10 s recycle delays and 10 µs dead time,
where the signals from about 8000 pulses were accumulated.
The chemical shift is represented in δ (ppm) by convention.
Polydimethylsilane (PDMS: δ = − 34.0 ppm against tetram-
ethylsilane: δ = 0 ppm) was used as the secondary external
reference. Samples for UV-vis study were placed in quartz
crystal cuvettes (path length 1 cm) and the absorption spectra
were acquired at room temperature using a UV-1601 spec-
trophotometer (Shimadzu).
2.3. MTT test
The cytotoxicity of the nanoparticles was evaluated by us-
ing the MTT test. MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide) is a yellow tetrazolium salt,
that is reduced only in living, metabolically active cell mi-
tochondria [13]. After reduction, a violet formazan dye
is formed and the amount of living cells can be quan-
tita3ted spectrophotometrically [13]. Hela (from cervix) and
L929 (from fibrosarcoma) cells were respectively cultivated
in Dulbecco’s modified Eagle’s medium (DMEM) supple-
mented with 10% fetal bovine serum (FBS), penicillin (100
IU/ml) and streptomycin (100 mg/ml) at 37◦C and 5% CO2.
In all, 5 × 104 cells were firstly seeded into each well of a
24-well plate and incubated for 48 h. The cell cultures were
then exposed to 200 µl of serial test specimens, toxic control
(Ctrl + , phenol, 10 mg/ml), and negative control (Ctrl-, com-
plete liquid culture medium) for 3, 12, and 24 h, respectively.
After incubation, 100 µl of MTT (0.5 mg/ml) was added to
each well and incubated at 37◦C for 4 h. At the end of the
assay, the blue formazan reaction product was dissolved by
adding 0.5 ml DMSO and transferred to a 96-well plate.
The absorbance was measured at 570 nm using a Bio-Rad
500 spectrophotometric microplate reader. Cell viability (as
a percent of the negative control) was calculated from the
absorbance values:
Cell viability (%) = Asample/Actrl− × 100
where Actrl− and Asample are the absorbance values for nega-
tive control and samples, respectively.
2.4. Hemolysis test
The Au-silicate nanoparticles were tested for limited hemo-
compatibility in vitro. A hemolysis test was done by modi-
fication of direct contact method. In short, blood from rats
was collected in heparin-coated tubes. 1 ml of blood diluted
with 9 ml of phosphate buffered saline (PBS, pH 7.4) and
0.2% Triton X-100 were taken as negative (0% hemolysis)
and positive (100% hemolysis) control, respectively. 200 µl
of serial test specimens were placed in a tube containing
10 ml of blood (1:10 diluted with PBS). The contents of all
the tubes were gently mixed and incubated in a water bath at
37◦C for 1 h. After 1 h incubation all tubes were centrifuged
at 2200 rpm for 5 min and the supernatant was taken for the
estimation of the release of hemoglobin. Absorbance was
recorded at 545 nm and non-toxic effect level was regarded
as less than 5% hemolysis in our experiments.
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2.5. Statistical analysis of the data
All samples were run in triplicate and experiments were
repeated 3 times. Data were presented as means ± standard
error of mean. Statistical significances between control and
treated groups were assessed using student t-test. P < 0.05
was considered statistically significant.
3. Results and discussion
The growth of Au-silicate nanoparticles was initiated when
HAuCl4 and sodium citrate was added to the APTMS sol.
Scheme 1 illustrates the synthetic route for making the Au-
silicate nanoparticles. Organosilane APTMS plays two main
roles in the formation of Au-silicate nanoparticles: it not
only formed a covalent link to gold particles through its
−NH2 end-group, but also produced silicate by hydrolysis
and polymerization of the trimethoxysilane group. In order
to confirm whether chemical interface effects played a main
role in the current system, we prepared the control nanopar-
ticles using 3-(glycidoxypropyl) trimethoxysilane (GPSM)
without amino groups, but under the identical experimental
conditions. For FT-IR spectroscopy, nanoparticles were re-
covered from solution by centrifugation at 15,000 rpm and
completely dried by freeze-drying. Figure 1 shows the FT-
IR spectra of the hydrolysed APTMS and GPSM as well as
the Au-silicate nanoparticles (from APTMS) and the con-
trol sample (from GPSM). Three types of organic groups
can be assigned to the peaks in the spectrum of the Au-
Scheme 1 The synthetic route for making the Au-silicate
nanoparticles


















Fig. 1 FT-IR spectra of (a) the Au-silicate nanoparticles by using
APTMS; (b) the APTMS gel without Au, and (c) the control sample by
using GPSM
silicate nanoparticles. The absorption peaks at 1030 and
1140 cm−1 corresponded to the asymmetric and symmet-
ric stretching vibration of Si–O–Si, whereas the peak at
458 cm−1 corresponded to the bending of the Si–O–Si bond.
The strong peaks in the stretching region at 2940 cm−1 and
the medium peaks in the bending/scissoring region from
1500–1300 cm−1 indicated the presence of both methylene
and methyl groups. A sharp band at 1590 cm−1 represented
the vibration of −NH. In contrast, no organic groups were
found for the control sample, indicating no silicate linked to
nanoparticles. Our previous works [14] and other literatures
[15] demonstrated that GPSM could be self-polymersized
to form R–Si–O–Si–R under the similar conditions. On the
other hand, the present concentration of silane was too low
to produce gelation [15]. The difference between the FT-IR
spectra for the Au-silicate nanoparticles and the control sam-
ple may be due to that APTMS reacted with the reduced Au
nanoparticles, whereas GPSM did not.
Figure 2 shows the X-ray diffraction patterns of the Au-
silicate nanoparticles, the control sample, and the APTMS
gel with the absence of HAuCl4, respectively. In the ab-
sence of HAuCl4, no crystalline phase was detected in-
dicating that silicate was amorphous. Au (111) and (200)
peaks were observed for the Au-silicate nanoparticles pre-
pared with APTMS and the control sample, respectively. We
calculated the grain size of the Au nanoparticles from the
Scherer equation as follows [16]:
D = 0.9λ/β cos θ
where D is the average crystallite size, λ is the X-ray wave-
length used, β is the angular line width of half-maximum
Springer
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Fig. 2 XRD patterns of (a) the Au-silicate nanoparticles by using
APTMS; (b) the control sample by using GPSM; and (c) the APTMS
gel without reducing HAuCl4
intensity, and θ is the Bragg’s angle in degrees. According
to the calculation, the grain size of Au for the Au-silicate
nanoparticles and the control sample were ∼ 4.4 nm and
∼17.6 nm, respectively. In the current systems, after aging
for 4 days, silane (i.e. APTMS and GPSM) was totally
hydrolyzed and polymerized. HAuCl4 was then reduced
by sodium citrate in the presence of silicate colloids.
The different crystalline size between the Au-silicate
nanoparticles (from APTMS) and the control sample (from
GPSM) thus suggested that the interaction between −NH2
and Au nanoparticles prevented the crystal growth of Au
nanocrystals.
The TEM images in Fig. 3(a) and (b) show the Au-
silicate nanoparticles (from APTMS) with a diameter of
10.7 ± 1.6 nm (averaged over measurement of 50 particles)
and the control samples (from GPSM) with a diameter of
35.5 ± 10.2 nm (averaged over measurement of 20 particles),
respectively. Note that the diffraction contrast was uniform,
suggesting a well-mixed hybrid material. The suspension re-
mained stable after a few month of storage. As shown in
Fig. 3(a), the uniform and spherical nanoparticles were well
dispersed. This could be due to the presence of APTMS or-
ganic spacers, which may induce a steric repulsion between
the nanoparticles.
UV-vis spectroscopy shows a typical sharp Au plasmon
peak located at 520 nm for the pure Au nanoparticles. In con-
trast, a broad absorption peak for the Au-silicate nanopar-
ticles was observed, which red shifted from 520 nm to the
near IR (NIR) region around 690 nm. The FWHM of this
peak was ∼230 nm. UV-vis spectrum for the control sam-
ple shows a similar characteristic as pure Au nanoparticles,
but completely different from what is obtained with aminosi-
lanes precursors (APTMS). As confirmed with FT-IR results,
we may assume that the Au nanoparticles may be separared
from GPSM solution by high speed centrifuging because no
chemically bonding occurred between the Au and the silicate,
whereas the Au-silicate nanoparticles were formed by using
APTMS. Hence, it may be suggested that this red-shift of
Au-silicate nanoparticles could be originated from the cou-
pling surface plasmon between neighbor gold nanoparticles
which dispersed in the silicate matrix [17, 18].
The optical results clearly established the role played by
the aminosilanes in binding and dispersing the metal ions in
addition to stabilizing the Au nanoparticles. 29Si CP-MAS
NMR spectroscopy was used to characterize the local en-
vironment of silicon atoms in the Au-silicate nanoparticles.
Fig. 3 TEM images of (a) the
Au-silicate nanoparticles; and
(b) the control sample by using
GPSM
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Fig. 4 UV-vis absorption spectra of (a) the Au nanoparticles; (b) the
control sample by using GPSM; (c) the Au-silicate nanoparticles by
using APTMS













Fig. 5 29Si CP-MAS NMR spectra of (a) the Au-silicate nanoparticles
by using APTMS; and (b) the APTMS gel without Au
The 29Si NMR spectra provide the proportions of Tn (n = 1;
2; or 3) species, where T represents a Si atom oxygen bridged
to n other Si atoms [14]. These allowed the quantification of
the degree of crosslinking of the silicate network. Both of
the Au-silicate nanoparticles and the APTMS gel (Fig. 5)
exhibited three characteristic absorption peaks, with chem-
ical shift of δ = −51, −57, −67 ppm, corresponding to T1,
T2, and T3 resonances, respectively. The relative abundances
of Tn (χn) were calculated from the integrated intensities of
the resonances in 29Si NMR spectra. The uncondensation
degree (η%) of Si-OH groups was calculated from the for-
mula: η% = 66.7χ1 + 33.3χ2. The content of Si–OH groups
(21.6%) was slightly higher than that of pure APTMS gel
(17.3%). This higher amount of uncondensed silicates could
be due to the covalent link between the amino groups and the
Au nanoparticles. The present results suggested that the pres-
ence of Au nanoparticles prevented the condensation process
of silicates.






















Fig. 6 Cell viability as a function of the concentration and the exposure
time of the Au-silicate nanoparticles
The cytotoxicity of nanoparticles is of great concern
in biomedical applications. The effects of the Au-silicate
nanoparticles on L929 cell viability were quantitatively
evaluated as shown in Fig. 6. Four different concentrations
(0.1, 1, 10, 50 µg/ml) were tested over 3, 12 and 24 h
exposure. Significant differences between the high and low
concentration of nanoparticles could be observed. As shown
in Fig. 6, incubation with 50 µg/ml Au-silicate nanoparticles
for 24 h showed a drastic cytotoxic effect in L929 cells. In
comparison, 1 µg/ml nanoparticles lowered L929 cell via-
bility to 74.0% and 42.3% after incubation for 12 and 24 h,
respectively. 0.1 µg/ml Au-silicate nanoparticles induced
only a slight decrease in cell viability, and therefore could
be considered as non-toxic. The mechanism of cytotoxicity
caused by nanoparticles is not yet fully understood. Whether
cytotoxic effects are mainly mediated by interactions of
nanoparticles with cell membranes or by cellular uptake and
subsequent activation of intracellular signal transduction
pathways remains controversial [19, 20]. Moreover, the
apoptotic or necrotic nature of the nanoparticles’ cytotoxic-
ity has to be taken into account in the further work. We also
observed that at lower concentration (<10 µg/ml), the L929
cells were shown to have a relationship between the loss
of viability and increasing concentration of nanoparticles,
while the Hela cells were relatively insensitive to incubation
in the presence of the Au-silicate nanoparticles. However,
the reason for a difference in the Au-silicate nanoparti-
cles effects between Hela and L929 cells is unclear at
present.
Hemolysis of the blood is another problem associated
with the bio-incompatibility of materials [21]. Red blood
cells hemolyze when they come in contact with water.
This problem may be aggravated in the presence of a
biomaterial. The interactions of the nanoparticles with the
negatively charged red blood cells have been studied by
hemolysis experiments [22]. The release of hemoglobin was
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Fig. 7 Hemolysis effects as a function of the concentration of the
Au-silicate nanoparticles
used to quantify the membrane-damaging properties of the
nanoparticles. As 100 and 0% values we used Triton X-100
and phosphate-buffer-treated erythrocytes, respectively.
Erythrocytes were incubated with 5 different nanoparticles
concentrations in the range of 0.01–10 µg/ml for 1 h
(Fig. 7). Autian [23] has reported that up to 5% hemolysis is
permissible for biomaterials. The Au-silicate nanoparticles
showed no hemolytic effects up to 1 µg/ml indicating no
detectable disturbance of the red blood cell membranes.
However, as increasing concentration to 10 µg/ml the
Au-silicate nanoparticles caused 34.51% hemolysis. It
may be concluded that the Au-silicate nanoparticles with
concentration <1 µg/ml are biocompatible and can be used
as drug carrier without causing any hemolysis.
4. Conclusions
In contrast to the observations in other works [9, 10],
here we fabricated the monodisperse Au-silicate nanopar-
ticles (10.7 ± 1.6 nm in diameter) with NIR sensitivity.
These Au-silicate nanoparticles were prepared by reduc-
tion of aqueous solution containing 2 mM HAuCl4 with
sodium citrate (1 wt.%) in a hydrosol, in which small clus-
ters of silicate formed by hydrolysis and polymerization
of 3-aminopropyltrimethoxysilane (APTMS). APTMS co-
valently linked to the reduced gold particles through its
−NH2 end-group. At lower concentration (<1 µg/ml), the
Au-silicate nanoparticles were biocompatible without caus-
ing cytotoxicity and hemolysis. The NIR active Au-silicate
nanoparticles are potential interesting candidates for biomed-
ical application.
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